Neoepitope Peptides Formulated in Immunovaccine's DepoVax(TM) Vaccine Platform Show Significant Positive Results in Preclinical Studies
03 nov. 2016 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 3, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine Appoints Gabriela Rosu, M.D., as Company's First Chief Medical Officer
01 nov. 2016 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 1, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine Announces Positive Phase 1 Topline Data for DepoVax(TM)-based Respiratory Syncytial Virus Vaccine Candidate
13 oct. 2016 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 13, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Positive Preclinical Data for Immunovaccine's DepoVax(TM)-based Malarial Vaccine Presented at 2016 World Vaccine Congress Europe
11 oct. 2016 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 11, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine to Present at 2016 BIO Investor Forum
06 oct. 2016 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 6, 2016) - Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will...
Immunovaccine Announces Transition of Chief Financial Officer Role
03 oct. 2016 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 3, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Researchers to Present Data on Immunovaccine's Infectious Disease Pipeline at Three International Conferences
23 sept. 2016 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 23, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical-stage vaccine and immunotherapy company,...
Immunovaccine to Present Pre-Clinical Data at the 2016 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival
20 sept. 2016 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 20, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical-stage vaccine and immunotherapy company,...
Immunovaccine Announces Dosing of First Patient in Phase 1b Clinical Trial for DPX-Survivac in Combination With Incyte's IDO1 Enzyme Inhibitor Epacadostat
08 sept. 2016 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 8, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine to Present at 2016 Rodman & Renshaw Global Investment Conference
01 sept. 2016 07h05 HE
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 1, 2016) - Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will...